906
Participants
Start Date
November 30, 2006
Primary Completion Date
February 28, 2010
Study Completion Date
February 28, 2010
Clopidogrel (SR25990)
"Form: reconstituted solution using Clopidogrel powder~Route: oral or enteric~Frequency: once daily~Dose: daily dose adjusted for weight"
placebo
"Form: reconstituted solution using matching placebo powder~Route: oral or enteric~Frequency: once daily~Dose: daily dose adjusted for weight"
Sanofi-Aventis Administrative Office, Bridgewater
Sanofi-Aventis Administrative Office, Buenos Aires
Sanofi-Aventis Administrative Office, Diegem
Sanofi-Aventis Administrative Office, São Paulo
Sanofi-Aventis Administrative Office, Laval
Sanofi-Aventis Administrative Office, Shangaï
Sanofi-Aventis Administrative Office, Hørsholm
Sanofi-Aventis Administrative Office, Cairo
Sanofi-Aventis Administrative Office, Helsinki
Sanofi-Aventis Administrative Office, Paris
Sanofi-Aventis Administrative Office, Berlin
Sanofi-Aventis Administrative Office, Causeway Bay
Sanofi-Aventis Administrative Office, Budapest
Sanofi-Aventis Administrative Office, Mumbai
Sanofi-Aventis Administrative Office, Netanya
Sanofi-Aventis Administrative Office, Milan
Sanofi-Aventis Administrative Office, Kuala Lumpur
Sanofi-Aventis Administrative Office, México
Sanofi-Aventis Administrative Office, Gouda
Sanofi-Aventis Administrative Office, Lysaker
Sanofi-Aventis Administrative Office, Warsaw
Sanofi-Aventis Administrative Office, Porto Salvo
Sanofi-Aventis Administrative Office, Moscow
Sanofi-Aventis Administrative Office, Singapore
Sanofi-Aventis Administrative Office, Midrand
Sanofi-Aventis Administrative Office, Seoul
Sanofi-Aventis Administrative Office, Barcelona
Sanofi-Aventis Administrative Office, Bromma
Sanofi-Aventis Administrative Office, Taipei
Sanofi-Aventis Administraive Office, Bangkok
Sanofi-Aventis Admnistrative Office, Guildford Surrey
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Sanofi
INDUSTRY